This sleeve invests in healthcare companies in developing and frontier markets. It targets businesses with resilient balance sheets, sound governance, and long-term visibility into demand across pharmaceuticals, diagnostics, biotechnology, medical devices, and healthcare services.
Updated 2025-10-30